Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review.
Alessio RizzoManuela RaccaSara Dall'ArmellinaRoberto C Delgado BoltonDomenico AlbanoFrancesco DondiFrancesco BertagnaSalvatore AnnunziataGiorgio TregliaPublished in: Diagnostics (Basel, Switzerland) (2023)
The available literature data in this setting are limited and heterogeneous. The employment of PET with PSMA-targeting radiopharmaceuticals in this setting did not affect patient management. Nevertheless, prospective multicentric studies are needed to properly assess its potential role in TC patients.